reports
Brenntag SE: 1 director
A director at Brenntag SE bought 700 shares at 71.277EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
DSV, 1110 - MAJOR SHAREHOLDER ANNOUNCEMENT
DSV, 1110 - MAJOR SHAREHOLDER ANNOUNCEMENT Company Announcement No. 1110 Pursuant to section 30 of the Danish Capital Markets Act it is announced that BlackRock, Inc. has informed DSV A/S that the total shares according to section 38 of the Danish Capital Markets Act, and other financial instruments according to section 39(2) of the Danish Capital Markets Act of DSV A/S held by BlackRock, Inc. as of 14 May 2024 correspond to below 5% of the entire share capital and below 5% of the voting rights of DSV A/S. ContactsInvestor Relations: Sebastian Rosborg, tel. , Yours sincerely,DSV ...
Lonking Holdings Ltd: 1 director
A director at Lonking Holdings Ltd sold 1,714,000 shares at 1.713HKD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Alliance Entertainment Holding Corp: 2 directors
Two Directors at Alliance Entertainment Holding Corp bought 23,000 shares at between 2.540USD and 2.550USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's...
Marinus Pharmaceuticals Announces Key Business Updates for Tuberous Sc...
RADNOR, Pa.--(BUSINESS WIRE)-- , Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced completion of enrollment in the global Phase 3 TrustTSC trial evaluating oral ganaxolone for the treatment of seizures associated with tuberous sclerosis complex (TSC) in children and adults. “We are pleased to announce we have completed enrollment in our pivotal Phase 3 trial in tuberous sclerosis complex,” said Alex Aimetti, Ph.D., Chief Scientific Officer at Marinus Pharmaceuticals. “The TrustTSC study enrolled hi...
NFI subsidiary New Flyer announces contract with BC Transit for 33 bat...
NFI subsidiary New Flyer announces contract with BC Transit for 33 battery-electric buses WINNIPEG, Manitoba, May 17, 2024 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) New Flyer Industries Canada ULC (New Flyer), a subsidiary of NFI Group Inc. (NFI) and leading manufacturer of heavy-duty transit buses, today announced a contract with BC Transit Corporation (BC Transit) for 33 next-generation Xcelsior CHARGE NG™ 40-foot battery-electric buses (BEBs). The contract was added to New Flyer’s firm backlog in 2024 Q2. BC Transit oversees municipal transit services for over 130 ...
Keskisuomalainen Oyj:n johtohenkilöiden liiketoimet - Kangaskorpi
Keskisuomalainen Oyj:n johtohenkilöiden liiketoimet - Kangaskorpi Keskisuomalainen Oyj, johtohenkilöiden liiketoimet, pörssitiedote 17.5.2024 klo 14.00 Keskisuomalainen Oyj - Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Vesa KangaskorpiAsema: ToimitusjohtajaLiikkeeseenlaskija: Keskisuomalainen OyjLEI: 743700J7NHT5OLSJ3B78Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 63169/4/4____________________________________________Liiketoimen päivämäärä: 2024-05-15Kauppapaikka: NASDAQ HELSINKI LTD (XHEL)Instrumenttityyppi: OSAKEISIN: FI0009007546Liiketoi...
Village Farms International Applauds Historic Move Toward U.S. Marijua...
Village Farms International Applauds Historic Move Toward U.S. Marijuana Rescheduling VANCOUVER, British Columbia and ORLANDO, Fla., May 17, 2024 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms”) (NASDAQ: VFF) applauds the U.S. Department of Justice’s historic decision to pursue federal rescheduling of marijuana for medical purposes to Schedule III from Schedule I under the Controlled Substances Act (CSA) (the “Rescheduling Proposal”). The Rescheduling Proposal starts a 60-day period for public comment. “We are encouraged by this continued regulatory progress and ar...
Autolus Therapeutics Reports First Quarter 2024 Financial Results and ...
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates Longer follow up and subset analyses from the pivotal FELIX Phase 2 data to be presented in oral presentations at ASCO and EHATwo patients enrolled in Phase 1 Systemic Lupus Erythematosus (SLE) trial; study on track for initial data end of 2024Market Authorization Application (MAA) for obe-cel in r/r adult ALL accepted by European Medicines Agency (EMA)Conference call to be held today at 08:30 am EDT/13:30 pm BST: conference call participants should pre-register using the link at the bottom of this press ...
Exchange Income Corporation Announces May 2024 Dividend
WINNIPEG, Manitoba--(BUSINESS WIRE)-- Exchange Income Corporation (TSX: EIF) (the “Corporation”), a diversified, acquisition-oriented company focused on opportunities in the aerospace & aviation and manufacturing segments, announced today that the Directors of the Corporation have declared eligible dividends totaling $0.22 per share for the month ended May 31, 2024 payable June 14, 2024 to shareholders of record at the close of business on May 31, 2024. Eligible shareholders have the opportunity to reinvest their dividends in accordance with the Corporation’s dividend reinvestment and share ...
Keskisuomalainen Oyj:n johtohenkilöiden liiketoimet - Kangaskorpi
Keskisuomalainen Oyj:n johtohenkilöiden liiketoimet - Kangaskorpi Keskisuomalainen Oyj, johtohenkilöiden liiketoimet, pörssitiedote 17.5.2024 klo 14.00 Keskisuomalainen Oyj - Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Vesa KangaskorpiAsema: ToimitusjohtajaLiikkeeseenlaskija: Keskisuomalainen OyjLEI: 743700J7NHT5OLSJ3B78Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 63171/4/4____________________________________________Liiketoimen päivämäärä: 2024-05-16Kauppapaikka: NASDAQ HELSINKI LTD (XHEL)Instrumenttityyppi: OSAKEISIN: FI0009007546Liiketo...
Virtu Financial Congratulates Michelle Hosea, Recipient of the Rising ...
Virtu Financial Congratulates Michelle Hosea, Recipient of the Rising Star Award at Women in Finance Asia Awards NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (Nasdaq:VIRT), a leading provider of global, multi-asset financial services that delivers liquidity and innovative, transparent products across the complete investment cycle to the global markets, is pleased to congratulate Michelle Hosea, Quantitative Strategist, on her Women in Finance Asia 2024 Rising Star Award. In Michelle’s three years at Virtu, she has quickly taken a leadership role on the quantitative ...
Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company...
Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that management will host 1x1 meetings with investors during the A.G.P. Virtual Healthcare Company Showcase, which is being held May 21, 2024. For more information, or to register: . About Psyence Biomed Psyence Biomedical Ltd., a corporation organized under the laws of Ontario, Canada, is the world’s first life science biotechnology company traded on The Nasdaq Stock Market LLC...
Chemomab Therapeutics to Participate in Upcoming Scientific Conference...
Chemomab Therapeutics to Participate in Upcoming Scientific Conferences TEL AVIV, Israel, May 17, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced upcoming scientific presentations at the Gordon Research Conference on Chemotactic Cytokines and at EASL 2024, the Annual Congress of the European Association for the Study of the Liver. The presentations cover a range of topics, from new preclinical studies further elucid...
JOYY to Announce First Quarter 2024 Financial Results on May 28, 2024
JOYY to Announce First Quarter 2024 Financial Results on May 28, 2024 SINGAPORE, May 17, 2024 (GLOBE NEWSWIRE) -- JOYY Inc. (NASDAQ: YY) (“JOYY” or the “Company”), a global technology company, today announced that it plans to release its first quarter 2024 financial results after the U.S. market closes on May 28, 2024. The Company’s management will host an earnings conference call at 9:00 PM U.S. Eastern Time on Tuesday, May 28, 2024 (9:00 AM Singapore/Hong Kong Time on Wednesday, May 29, 2024). Details for the conference call are as follows: Event Title:JOYY Inc. First Quarter 2024 E...
Rego Payment Architectures, Inc. Announces Completion of Its $25 Milli...
Rego Payment Architectures, Inc. Announces Completion of Its $25 Million Series B Preferred Stock Financing Rego Payment Architectures, Inc. completes its Series B Preferred Stock private placement, increasing the total capital raised to over $100 million. BLUE BELL, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Rego Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT), today announced that it has raised an additional $3.5 million through the private placement of 38,889 shares of the company’s Series B Preferred Stock, which completes its $25 million Series B Preferred Stock offering. Peter S. Pe...
EQS-News: One Square Advisory Services S.à.r.l.: Golden Gate GmbH – 18...
EQS-News: One Square Advisory Services S.à.r.l. / Schlagwort(e): Anleihe/Insolvenz One Square Advisory Services S.à.r.l.: Golden Gate GmbH – 18. Sachstandsbericht gegen Nachweis der Anleihegläubigerstellung verfügbar 17.05.2024 / 12:54 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. One Square Advisory Services S.à.r.l.: Golden Gate GmbH – 18. Sachstandsbericht gegen Nachweis der Anleihegläubigerstellung verfügbarMünchen, 17. Mai 2024 - Der Insolvenzverwalter der Golden Gate GmbH hat der One Square Advisory Services S.à.r.l. in ihrer ...
- Haidje Rustau
Bite - Earnings Flash - Q1 FY 2024 Results - Lucror Analytics
Bite has delivered solid Q1/24 results, with y-o-y increases in revenues and EBITDA. The recent price hikes appear to have been received fairly well, and should be supportive of ARPU and the margins going forward. We note the continued strong growth in pay-TV and broadband. An increasingly converged customer base should result in lower churn, and this should also help to diversify earnings. We believe that Bite will access the bond markets soon, and expect this to go hand in hand with a divi...
United Energy Group Ltd: 1 director
A director at United Energy Group Ltd sold 90,000,000 shares at 0.640HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Devsisters Co Ltd: 1 director
A director at Devsisters Co Ltd sold 10,000 shares at 54,700.000KRW and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.